Considering the Impact of Personalized Medicine
Logistics and transportation firm Quick Specialized Healthcare Logistics offers insights into managing developing therapeutic treatments through the life sciences supply chain.
When the Precision Medicine Initiative (PMI) was launched in January 2015 as “a bold new research effort to revolutionize how we improve health and treat disease,” according to The White House, it brought challenges to the entire healthcare supply chain.
The U.S. FDA’s website, for example, said, “The vast amount of information generated through next-generation sequencing (NGS) poses novel regulatory issues for FDA.”
It’s worth watching how packaging and logistics functions will adapt to accommodate these therapies, perhaps especially so for companies in the temperature-sensitive supply chain.
Source: Life Science Logistics